Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5027 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 5 out of 11
105 citations found

Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease

Garretti, F;Monahan, C;Sloan, N;Bergen, J;Shahriar, S;Kim, SW;Sette, A;Cutforth, T;Kanter, E;Agalliu, D;Sulzer, D;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Immunizations

    8- to 12-week-old male and female mice were immunized subcutaneously with a 100 μl emulsion of 100 μg α-syn32-46 peptide (A&A peptides; San Diego, CA) dissolved in PBS with Complete Freund Adjuvant (CFA) containing 200 μg M. tuberculosis H37Ra (BD Difco Adjuvant, Fisher Scientific, Cat #DF0638-60-7; Waltham, MA). The day of immunization was designated as day 0. Mice received a boost with the same immunization dose two weeks later. Mice received intravenous injections of 400 ng of B. pertussis toxin (List Biological Laboratories, Cat #181; Campbell, CA) 14- and 16-days post-initial immunization (day 0 and 2 post boost). …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis optica spectrum disorder in mice

Serizawa, K;Miyake, S;Katsura, Y;Yorozu, K;Kurasawa, M;Tomizawa-Shinohara, H;Yasuno, H;Matsumoto, Y;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • 2.2. Immunization

    Mice were immunized with 200 or 400 μg of AQP4 p201–220 peptide TFA salt (synthesized by Peptide Institute, Inc., Osaka, Japan) emulsified in complete Freund’s adjuvant (CFA), which was made by supplementation of Mycobacterium tuberculosis extract H37Ra (231141; BD, Franklin Lakes, NJ, USA) to incomplete Freund’s adjuvant (263910; BD). A total of 100 μL of CFA was injected intradermally at 15 sites from the base of the tail to the back on Day 0. In addition, mice received 300 or 500 ng pertussis toxin (181; List Biological Laboratories, Campbell, CA, USA) intravenously on Day 0 and intraperitoneally on Day 2. In the experiments establishing AQP4 peptide-immunized mice, we used 400 μg of AQP4 peptide; in the experiments evaluating the effects of IL-6 signal inhibition, we used 200 μg of AQP4 peptide to avoid problems such as death or skin ulcers during the experiment. Control mice were treated with complete Freund’s adjuvant and saline alone.

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

RORψt+CD4+ T cells promote IL-23R-mediated neuronal cell apoptosis in the central nervous system

Sonar, S;Metei, T;Inamdar, S;Lenka, N;Lal, G;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Pertussis toxin List Biologicals Laboratories (Campbell, CA) Cat# 181

    Induction of active EAE

    Active EAE was induced by subcutaneous (s.c.) injection of MOG35-55 (MOG) peptide (200 µg/mouse) emulsified in complete Freund’s adjuvant (CFA) containing Mycobacterium tuberculosis H37Ra (5 mg/ml) at the flanks of mice. Pertussis toxin (200 ng/mouse) was given intravenously (i.v.) on days 0 and 2. The mice were observed daily for the development of clinical symptoms, and mice were clinically scored.

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes

Yu, C;Ruan, Y;Sun, X;Chen, C;Shen, T;Liu, C;Qiu, W;Lu, Z;Chan, SO;Wang, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Phosphoenolpyruvate regulates the Th17 transcriptional program and inhibits autoimmunity

Huang, TY;Hirota, M;Sasaki, D;Kalra, RS;Chien, HC;Tamai, M;Sarkar, S;Mi, Y;Miyagi, M;Seto, Y;Ishikawa, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Pertussis toxin List Labs Cat#181

    EAE induction
    8-week-old, female C57BL/6 mice were s.c. injected with MOG35–55 peptides (300 mg per mouse) emulsified in complete Freund’s adjuvant (CFA) (200 μL per mouse) containing dead Mycobacterium tuberculosis (1 mg per mouse) on day 0. On days 0 and 2, pertussis toxin (400 ng per mouse) was intraperitoneally injected into mice. …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Differential Effects of SARM1 Inhibition in Traumatic Glaucoma and EAE Optic Neuropathies

Liu, P;Chen, W;Jiang, H;Huang, H;Liu, L;Fang, F;Li, L;Feng, X;Liu, D;Dalal, R;Sun, Y;Jafar-Nejad, P;Ling, K;Rigo, F;Ye, J;Hu, Y;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • EAE induction and clinical scoring

    EAE/optic neuritis was induced with MOG (MOG33-55, GenScript, cat. no.163913-87-9) peptide and PTX (List Biological Laboratories, Campbell, CA, USA, cat. no. 181) in 9-week-old female mice with a procedure modified from the established protocol.29,30,44 Briefly, 225 μg MOG33-55 peptide emulsified with incomplete Freund’s adjuvant (IFA; BD Difco, 263910) and 2.5 mg/mL mycobacterium tuberculosis (BD Difco, 231141) were injected subcutaneously for immunization twice at days 0 and 7, and 500 ng PTX in PBS (2.5 μg/mL) was intraperitoneally injected twice at days 0 and 2 to break down the blood-brain barrier. Mice injected with the same volume of Freund’s adjuvant emulsion without MOG33-55 were used as sham controls. …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Estrogen receptor alpha signaling in dendritic cells modulates autoimmune disease phenotype in mice

Khaw, YM;Anwar, S;Zhou, J;Kawano, T;Lin, PC;Otero, A;Barakat, R;Drnevich, J;Takahashi, T;Ko, CJ;Inoue, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

α-Synuclein Induces Neuroinflammation Injury through the IL6ST-AS/STAT3/HIF-1α Axis

Lin, D;Zhang, H;Zhang, J;Huang, K;Chen, Y;Jing, X;Tao, E;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Metabolic Interventions for Multiple Sclerosis

Zyla-Jackson, K;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • Active EAE was induced in 9-12 week-old male and female mice by subcutaneous injection of 150µg of mouse myelin oligodendrocyte glycoprotein peptide (residues 35-55; MOG35-55) (Genemed Synthesis, Inc., San Francisco, USA) emulsified in Complete Freund’s Adjuvant (CFA) (Thermo Fisher Scientific; DF0639606) containing 5 mg/mL heat-inactivated Mycobacterium tuberculosis (Thermo Fisher Scientific; DF3114338). 250 ng of Bordetella pertussis toxin (List Biological Laboratories, Inc. #181) was administered intraperitoneally on the day of immunization and 48 hours later …

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)